These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28882471)

  • 1. Arginine vasopressin improves the memory deficits in Han Chinese patients with first-episode schizophrenia.
    Geng CH; Wang C; Yang J; Wang H; Ma RQ; Liu X; Wang CH
    Peptides; 2017 Nov; 97():8-15. PubMed ID: 28882471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia.
    Wang CH; Li Y; Yang J; Su LY; Geng YG; Li H; Wang JK; Mu JL
    Schizophr Res; 2013 Mar; 144(1-3):129-35. PubMed ID: 23352776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
    Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.
    Xiao S; Xue H; Li G; Yuan C; Li X; Chen C; Wu HZ; Mitchell P; Zhang M
    Aust N Z J Psychiatry; 2012 Feb; 46(2):153-60. PubMed ID: 22311531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive psychopathology in Schizophrenia: Comparing memory performances with Obsessive-compulsive disorder patients and normal subjects on the Wechsler Memory Scale-IV.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2016 Jun; 28(2):118-26. PubMed ID: 27287785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial.
    Akhondzadeh S; Mohammadi N; Noroozian M; Karamghadiri N; Ghoreishi A; Jamshidi AH; Forghani S
    Schizophr Res; 2009 Feb; 107(2-3):206-12. PubMed ID: 18789844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia.
    Xiao SF; Xue HB; Li X; Chen C; Li GJ; Yuan CM; Zhang MY
    Neurosci Bull; 2011 Aug; 27(4):258-68. PubMed ID: 21788997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300.
    Higuchi Y; Sumiyoshi T; Kawasaki Y; Matsui M; Arai H; Kurachi M
    Schizophr Res; 2008 Apr; 101(1-3):320-30. PubMed ID: 18321680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans.
    Dodt C; Pietrowsky R; Sewing A; Zabel A; Fehm HL; Born J
    J Gerontol; 1994 Jul; 49(4):M183-8. PubMed ID: 8014393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trial.
    Li H; Luo J; Wang C; Xie S; Xu X; Wang X; Yu W; Gu N; Kane JM
    Schizophr Res; 2014 Aug; 157(1-3):112-9. PubMed ID: 24994555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intranasal arginine vasopressin on human headache.
    Yang J; Lu L; Wang HC; Zhan HQ; Hai GF; Pan YJ; Lv QQ; Wang DX; Wu YQ; Li RR; Xue L; Wang XH; Deng XM; Liu XF; Qian YN; Deng ZK; Zhang ZJ; Zhan XH; Zhou XJ; Wang GL; Zhai JX; Wang JC
    Peptides; 2012 Nov; 38(1):100-4. PubMed ID: 22963731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin and cognitive processes: two event-related potential studies.
    Naumann E; Bartussek D; Kaiser W; Fehm-Wolfsdorf G
    Peptides; 1991; 12(6):1379-84. PubMed ID: 1815224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia.
    Schaefer M; Sarkar S; Theophil I; Leopold K; Heinz A; Gallinat J
    Pharmacopsychiatry; 2020 Jan; 53(1):21-29. PubMed ID: 31390660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Zhang X; Zhao F; Wang C; Zhang J; Bai Y; Zhou F; Wang Z; Wu M; Yang W; Guo J; Qi J
    Neurosci Bull; 2020 Mar; 36(3):254-262. PubMed ID: 31605298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders.
    Breier A; Liffick E; Hummer TA; Vohs JL; Yang Z; Mehdiyoun NF; Visco AC; Metzler E; Zhang Y; Francis MM
    Schizophr Res; 2018 Sep; 199():395-402. PubMed ID: 29588126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.
    Fan X; Liu E; Freudenreich O; Copeland P; Hayden D; Ghebremichael M; Cohen B; Ongur D; Goff DC; Henderson DC
    J Clin Psychopharmacol; 2013 Apr; 33(2):226-30. PubMed ID: 23422397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.